09 Nov 20 | All | Formycon, Bioeq | Formycon and Bioeq announces they have commenced dosing in Ph III trials of FYB202 (proposed ustekinumab biosimilar) in patients with moderate to severe plaque psoriasis.

28 Oct 20 | All | Amgen | In its Q3 2020 financial results, Amg...

December 3, 2019

02 Dec 2019 | Alvotech, Kamada | Alvotech and Kamada announce agreement to commercialise six biosimilar products in Israel. The first product is expected to be launched in Israel in 2022.

06 Nov 2019 | All | Biogen, Samsung Bioepis | Biogen and Samsung Bioepis announce ...

Please reload

Biosimilars bulletin 

November 9, 2020

Please reload

Search by tags